12:00 AM
 | 
May 17, 1999
 |  BC Week In Review  |  Company News  |  Deals

Onyvax, Cancer Research Campaign Technology Ltd. deal

Onyvax received an exclusive worldwide license from Cancer Research Campaign Technology (CRCT) to a cancer vaccine based on an antibody that...

Read the full 83 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >